News | Page 51 | Weill Department of Medicine

Dr. Downs and Colleagues Publish Paper in Academic Medicine on Promoting Women in Global Health

Dr. Jennifer Downs, Assistant Professor of Medicine in the Division of Infectious Diseases, is first author on a paper published in Academic Medicine (August 2014), entitled "Increasing Women in Leadership in Global Health". The paper focuses on solutions aimed at promoting female leaders from both resource-wealthy and resource-poor countries and highlights challenges such as climbing institutional career ladders, tensions between career and family responsibilities, and health and safety issues... Read More

New Function of a Well-known Enzyme Linked to Virulence of TB Bacterium: Dr. Rhee and Colleagues Publish Findings in Nature Communications

Dr. Kyu Rhee, Associate Professor of Medicine, Division of Infectious Diseases, and colleagues have uncovered a link between the function of a well-known enzyme and the virulence of the TB bacterium. Their findings are helping to uncover why the TB bacterium is naturally resistant to antibiotic treatment, and they suggest a strategy that could make new and existing drugs more powerful in treating TB. TB is the world's leading bacterial cause of death.Related LinksWeill Cornell Newsroom

Vascular Bed to Bedside: Engineered Blood Cells Could Cure Diseases

In an advance that could eventually offer patients with blood disorders curative therapies derived from their own cells, researchers at the Ansary Stem Cell Institute, WCMC, have been able to directly reprogram vascular cells to long-lasting blood cells that resemble bone marrow stem cells capable of forming the various components of blood necessary for life. Dr. Shahin Rafii is a Professor of Medicine and the Director of the Ansary Stem Cell Institute.The findings, reported as an article in... Read More

The Department of Medicine Annual Investigators Award Recipients of 2014

The 23rd Annual Department of Medicine Awards were announced on June 17, 2014. This award is presented annually to members of the Weill Department of Medicine below the rank of professor who perform on outstanding levels in the areas of clinical and/or basic biomedical research. It is supported by the Michael Wolk Foundation.WinnerManish Shah, MDDivision: Hematology and Medical OncologyA Novel Mechanism of Taxane Resistance in Gastric Cancer from Bedside to Bench, and Back AgainRunner-UpNaina... Read More

The 2014 Fellow Award in Research Finalists Announced at Medicine Grand Rounds

Initiated in 2002, the Fellow Award in Research is presented annually to fellows within the Weill Department of Medicine who have presented outstanding research. This year's finalists were announced at the June 10 Medicine Grand Rounds (12th Annual).(L to R): Drs. Augustine M.K. Choi (Chair), José Alemán, Ashita Batavia, and Sarah RutherfordWinnerAshita S. Batavia, M.D.Fellow, Infectious DiseaseLong-Term Effect of Early versus Delayed Antiretroviral Therapy in HIV-Infected Patients in Port-au-... Read More

The 2014 David E. Rogers Memorial Research Award Finalists Announced at Medicine Grand Rounds

Established in 1995, the David E. Rogers Memorial Research Award encourages medical residents to continue their investigative research in internal medicine. Each year, senior medical residents submit research abstracts, and four finalists are chosen to present their work during medical grand rounds.The award was founded and is chaired by Holly S. Andersen, MD, Director of Education and Outreach at The Ronald O. Perelman Heart Institute (and Associate Attending Physician at NewYork-Presbyterian... Read More

Suthanthiran Lab Discovery Selected as One of Top 10 Clinical Research Achievements in U.S.

Dr. Califf, Dr. Suthanthiran, Dr. Pardes

L to R: CRF Chair Dr. Robert Califf; Dr. Manikkam Suthanthiran; CRF Vice Chair Dr. Herbert PardesThe Suthanthiran Laboratory's innovative discovery to determine acute rejection in the kidney transplant (by measuring three genes in the urine), and ultimately reducing the need of a kidney transplant biopsy, was selected as one of Top 10 Outstanding Clinical Research Achievements in the U.S. by the Clinical Research Forum.The Clinical Research Forum is an organization comprised of the nation's... Read More

Weill Cornell Department of Medicine's Employee Recognition Program: Four Superstars Announced

The Employee Recognition Review Committee (R3) of the Joan and Sanford I. Weill Department of Medicine completed its bimonthly review of all nominees and four superstar winners were announced: Ashley Miltenberger, Research Coordinator (Infectious Diseases), Sloane Carrico, Senior Medical Secretary (Hematology/Medical Oncology), Tony Nepomuceno, Patient Coordinator (Endocrinology, Diabetes and Metabolism/Weight Management and Metabolic Research Center), and Nadine Sylvain, Payroll Manager (Weill... Read More

Dr. Logio Becomes President-Elect of the APDIM

Dr. Lia Logio, Vice Chair for Education and Director of the Internal Medicine Residency Program (Weill Department of Medicine), has been named President-Elect of the Association of Program Directors in Internal Medicine (APDIM). An APDIM Annual Awards Luncheon will be hosted by the APDIM where Dr. Logio will be celebrated for this prestigious honor. The Weill Department of Medicine salutes Dr. Logio in recognition of her outstanding leadership in furthering the department's educational mission.

Dr. Murray's Investigation Leads to FDA Approval of First Effective Oral Agent for Leishmaniasis

Dr. Henry W. Murray, Arthur R. Ashe Professor of Medicine (and former Chief of the Division of Infectious Diseases), has been working on leishmaniasis, in the laboratory and clinically, for nearly 35 years. For 15 years he carried out clinical treatment trials research in visceral leishmaniasis ("kala-azar") India. The drug he and colleagues in India introduced and tested in the treatment of kala-azar, miltefosine, has been approved by the FDA as the first effective oral agent for leishmaniasis... Read More